LTA | Lymphotoxin alpha | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
LY86 | Lymphocyte antigen 86 | Predicted secreted proteins
| | | | | Tissue enhanced |
LY9 | Lymphocyte antigen 9 | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
MAP4K1 | Mitogen-activated protein kinase kinase kinase kinase 1 | Enzymes
| | | | | Tissue enhanced |
MDS2 | Myelodysplastic syndrome 2 translocation associated | Disease related genes
| | | | | Tissue enhanced |
MIXL1 | Mix paired-like homeobox | Transcription factors
| | | | | Tissue enhanced |
MMP9 | Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MYBL1 | V-myb avian myeloblastosis viral oncogene homolog-like 1 | Plasma proteins Transcription factors
| | | | | Tissue enhanced |
MYBL2 | V-myb avian myeloblastosis viral oncogene homolog-like 2 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
NCR3 | Natural cytotoxicity triggering receptor 3 | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
NT5DC4 | 5'-nucleotidase domain containing 4 | | | | | | Tissue enhanced |
NUGGC | Nuclear GTPase, germinal center associated | | | | | | Tissue enhanced |
OCM | Oncomodulin | | | | | | Tissue enhanced |
P2RY10 | Purinergic receptor P2Y, G-protein coupled, 10 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
P2RY8 | Purinergic receptor P2Y, G-protein coupled, 8 | Cancer-related genes G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PARP15 | Poly (ADP-ribose) polymerase family, member 15 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
PASK | PAS domain containing serine/threonine kinase | Enzymes
| | | | | Tissue enhanced |
PATL2 | Protein associated with topoisomerase II homolog 2 (yeast) | Predicted secreted proteins
| | | | | Tissue enhanced |
PAX5 | Paired box 5 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
PDCD1 | Programmed cell death 1 | CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
PDE6G | Phosphodiesterase 6G, cGMP-specific, rod, gamma | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
PMCH | Pro-melanin-concentrating hormone | Predicted secreted proteins
| | | | | Tissue enhanced |
PNOC | Prepronociceptin | Predicted secreted proteins
| | | | | Tissue enhanced |
POU2AF1 | POU class 2 associating factor 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enhanced |
POU2F2 | POU class 2 homeobox 2 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
PTCRA | Pre T-cell antigen receptor alpha | Predicted membrane proteins
| | | | | Tissue enhanced |
PTPN7 | Protein tyrosine phosphatase, non-receptor type 7 | Cytoskeleton related proteins Enzymes
| | | | | Tissue enhanced |
PTPRCAP | Protein tyrosine phosphatase, receptor type, C-associated protein | Predicted secreted proteins
| | | | | Tissue enhanced |
PVRIG | Poliovirus receptor related immunoglobulin domain containing | Predicted membrane proteins
| | | | | Tissue enhanced |
PYHIN1 | Pyrin and HIN domain family, member 1 | | | | | | Tissue enhanced |
RAPGEF6 | Rap guanine nucleotide exchange factor (GEF) 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
RASAL3 | RAS protein activator like 3 | RAS pathway related proteins
| | | | | Tissue enhanced |
RGS13 | Regulator of G-protein signaling 13 | | | | | | Tissue enhanced |
RHOH | Ras homolog family member H | Cancer-related genes Disease related genes
| | | | | Tissue enhanced |
RLTPR | RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing | | | | | | Tissue enhanced |
RP11-296A16.1 | | | | | | | Tissue enhanced |
RP11-796G6.2 | Uncharacterized protein | | | | | | Tissue enhanced |
S1PR4 | Sphingosine-1-phosphate receptor 4 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
SASH3 | SAM and SH3 domain containing 3 | | | | | | Tissue enhanced |
SCML4 | Sex comb on midleg-like 4 (Drosophila) | | | | | | Tissue enhanced |
SEPT1 | Septin 1 | | | | | | Tissue enhanced |
SEPT1 | Uncharacterized protein | | | | | | Tissue enhanced |
SERPINA9 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9 | Predicted secreted proteins
| | | | | Tissue enhanced |
SH2D1A | SH2 domain containing 1A | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
SHOX2 | Short stature homeobox 2 | Transcription factors
| | | | | Tissue enhanced |
SIRPG | Signal-regulatory protein gamma | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
SLAMF1 | Signaling lymphocytic activation molecule family member 1 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SLAMF6 | SLAM family member 6 | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
SLAMF8 | SLAM family member 8 | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
SNX20 | Sorting nexin 20 | | | | | | Tissue enhanced |